Geode Capital Management, LLC Moleculin Biotech, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.38 - $0.72 $83 - $157	219 Added 0.09%	246,670 $106,000
Q4 2022 Feb 13, 2023	SELL	$0.85 - $1.49 $510 - $894	-600 Reduced 0.24%	246,451 $261,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $2.0 $1,712 - $2,878	1,439 Added 0.59%	247,051 $358,000
Q3 2021 Nov 12, 2021	BUY	$2.7 - $3.59 $21,670 - $28,813	8,026 Added 3.38%	245,612 $736,000
Q2 2021 Aug 13, 2021	BUY	$3.21 - $4.06 $201,472 - $254,821	62,764 Added 35.9%	237,586 $871,000

Q1 2021 May 12, 2021	BUY	$3.7 - $6.42 $646,841 - $1.12 Million	174,822 New	174,822 $713,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $124M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.